Antimicrobials

Ertapenem

C. diff Risk

Medium

Oral Bioavailability

NA

Approximate Cost

~$50/day

Dosing

1g IV q24h

General information

Targeted therapy of ESBL infections and other resistant gram negative infections.

Empiric therapy when broad spectrum of carbapenems is desired without the need for anti-pseudomonal activity.

  • Immediate and delayed-type allergy

  • GI disturbance

  • Cytopenias, eosinophilia, positive Coombs

  • Liver enzyme abnormalities

  • Seizure risk lower than other carbapenems

Antimicrobial class: Carbapenem

Pregnancy category: B

Average serum half life: 4.0

Biliary penetration: Moderate

Lung penetration: Therapeutic

Urine penetration: Therapeutic